BioPhy

BioPhy, developed by Intrinsic Clinical Systems, is an AI-powered platform designed to help regulatory, quality, and operations teams in life sciences navigate complex compliance requirements and documentation with greater speed and accuracy. By combining a regulatory research engine with a QMS gap analysis solution, BioPhy enables organizations to rapidly locate, synthesize, and operationalize regulatory and scientific information — reducing the burden of manual research and strengthening overall inspection readiness.

The platform is purpose-built for teams managing SOPs, quality documentation, and regulatory alignment across departments and regions. BioPhy's hybrid AI engine is engineered to outperform standard open-source LLM methods without requiring months of fine-tuning, making it a practical, enterprise-ready solution for organizations seeking continuous quality improvement.

Core Capabilities

• Regulatory Research Engine: Enables teams to rapidly locate, synthesize, and operationalize regulatory and scientific information across authoritative sources and internal knowledge bases, supporting faster answers to critical compliance questions.
• QMS Gap Analysis: Assesses alignment between current SOPs, quality documentation, and applicable regulatory requirements, identifying gaps and prioritizing remediation opportunities to strengthen inspection readiness.
• SOP Harmonization: Surfaces document duplication across departments and regions and consolidates document drafting to reduce redundancy and inconsistency.
• Version Control Intelligence: Surfaces the most recent, authoritative versions of SOPs and flags outdated or unapproved drafts to prevent accidental use of incorrect procedures.

Key Features and Benefits

• Quality Compliance Efficiencies: Reduces manual review by 85%, automatically identifies misalignments between SOPs and regulations, and provides compliance risk scoring alongside remediation recommendations.
• 30% Better Accuracy: BioPhy's hybrid engine consistently outperforms open-source LLM methods in identifying regulatory gaps, without requiring months of fine-tuning or ongoing maintenance.
• Rapid Results: Continuous monitoring flags new compliance gaps within hours of any SOP or regulatory revision, converting weeks of clerical work into a simple dashboard refresh.
• Stay Focused on Core Science Work: Frees data science and quality teams to focus on patient impact work rather than front-end state management or validation paperwork.

Enterprise Deployment and Scalability

• Enterprise-Ready Infrastructure: BioPhy is deployed on GPU-backed infrastructure sized for billion-vector indexes, eliminating the need for significant capital expenditure, lengthy hardware procurement timelines, or concerns about rate limits.
• Designed to scale with organizational growth without requiring substantial upfront infrastructure investment.
• Supports continuous improvement processes by automatically monitoring regulatory and SOP changes and surfacing actionable insights in real time.

BioPhy is offered as part of the broader Intrinsic Clinical Systems product suite, which also includes CTMS, Insights RM, and Informer solutions. Organizations interested in transforming their regulatory and quality operations can request a demo directly through Intrinsic Clinical Systems.